arrow
M

Marc-André Langlois

University of Ottawa
H指数:29
被引数:3,629

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Three Doses and Six Months Later: Real-World SARS-CoV-2 Specific Humoral and Cell-Mediated Immunity in Children With Inborn Errors of Immunity

三剂接种六个月后:先天性免疫缺陷儿童中SARS-CoV-2特异性体液和细胞介导的免疫的实际情况

2026-04-250
OAAI
The human gut microbiome primes fever after vaccination

疫苗接种后人体肠道微生物组对发热的诱导作用

Science
IF45.8
2026-01-010
PRE
Infection Rate and Risk Factors of SARS-CoV-2 Infection in Retail Workers at the Onset of the COVID-19 Pandemic, Quebec, Canada

SARS-CoV-2感染率及风险因素:加拿大魁北克零售业工作者COVID-19大流行初期的感染情况

2025-08-240
PRE
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignancies

多剂量SARS-CoV-2疫苗接种在血液恶性肿瘤患者中的增量免疫原性

2025-07-300
OAAI
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity

mRNA疫苗诱导的SARS-CoV-2刺突特异性ifn-γ 和IL-2 T细胞反应可预测血清学中和作用,并通过预先存在的交叉反应免疫而瞬时增强

2025-01-310
OAAI
Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves

在Omicron变体波期间,基于人群的HIV感染者队列和匹配的非HIV感染者队列的冠状病毒疾病2019结果

AIDS
IF3.1
2024-07-110
OAAI
Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study

新型冠状病毒肺炎后疾病的临床和血清学预测因素-来自加拿大前瞻性队列研究的结果

2024-05-092
OAAI
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study

HIV感染者突破性SARS-CoV-2感染的相关性: CIHR CTN 328研究的结果

2024-04-231
OAAI